Eight new 9,10-anthraquinones (1-8) including three acetonide derivatives of 3-hydroxy-2-hydroxymethyl-9,10-anthraquinones (6-8) were isolated from an ethanol extract of the roots of Knoxia valerianoides. On the basis of chemical transformation reactions of the co-occurring 14 and 15 combined with HPLC-DAD-ESI-MS analysis of the extracts, the previously and newly isolated 2-methoxymethyl-and 2-ethoxymethyl-9,10-anthraquinones (4, 5, and 9-13), as well as the 3hydroxy-2-hydroxymethyl-9,10-anthraquinone acetonide derivatives (6-8), were shown to be solvolytic artifacts. In the in vitro assays, compound 4 was active to protect hepatocyte (WB-F344) damage.
Introduction
Knoxia valerianoides Thorel ex Pitard is one of the only two Knoxia species (Rubiaceae) distributed in the Chinese mainland. The dried roots are commonly used as purgative and anti-ulcer medicine. Chemical and pharmacological investigation indicated that it mainly contained 9,10-anthraquinones, with inhibitory activities against the formation of advanced glycation end products and rat lens aldose reductase [1] [2] [3] [4] [5] . As part of a programme to assess the chemical and biological diversities of traditional Chinese medicines 6-10 , we investigated an ethanol extract of the roots of K. valerianoides. In our previous study, five new 9,10anthraquinones including a dihydrofurano-9,10-anthraquinone 11 , together with 21 known analogues 12 , were isolated from an ethanol extract of the roots of K. valerianoides. Continuing examination of the same extract led to the characterisation of eight new anthraquinones including three acetonide derivatives of 3-hydroxy-2-hydroxymethyl-9,10-anthraquinones (1) (2) (3) (4) (5) (6) (7) (8) . Although several 2-methoxymethyl-and 2-ethoxymethyl-9,10-anthraquinones (9) (10) (11) (12) (13) were previously reported as natural products from this plant 1, 3, 11, 12 , chemical transformation of the co-occurring 14 and 15 and HPLC-ESI-MS analysis of the plant extracts showed that the reported 1, 3, 11, 12 and isolated analogues (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) were solvolytic artifacts formed in the extraction and isolation. In addition, it was found that the acetonide (S16) of 3-hydroxy-2hydroxymethyl-1-methoxy-9,10-anthraquinone (16) was decomposed by oxidation into two major products, damnacanthal (S16a) and 2-carboxyl-3-hydroxy-1-methoxy-9,10-anthraquinone acetonide (S16b) ( Fig. 1 ).
Results and discussion
Compound 1, an orange amorphous solid, showed IR absorptions for hydroxy (3523 and 3457 cm À1 ), conjugated carbonyl (1675 cm À1 ), and aromatic ring (1626, 1592 cm À1 ) functional groups. The molecular formula of 1 (C 15 H 10 O 5 ) was indicated by (À)-HR-ESI-MS at m/z 269.0451 [M-H] À (calcd. for C 15 H 9 O 5 , 269.0455) combined with the NMR data (Tables 1  and 2 ). The 1 H NMR spectrum of 1 showed resonances attributed to a pair of meta-coupled aromatic protons at d 6.65 (d, J¼ 2.5 Hz, H-2) and 7.24 (d, J¼ 2.5 Hz, H-4), a set of ortho-meta-coupled ABX aromatic protons at d 7.63 (d, J¼2. 5 Hz, H-5), 7.40 (dd, J¼8.5 and 2.5 Hz, H-7), and 8.21 (d, J¼8. 5 Hz, , an aromatic methoxy group at d 4.02 (s, OMe-6), a hydrogen bonded phenolic hydroxy proton at d 12.95 (s, OH-1), and a broadened phenolic hydroxy proton at d 9.92 (brs, OH-3). This indicated the presence of two aromatic rings in 1, having tetra-and trisubstituted patterns, respectively. The 13 C NMR spectrum of 1 showed a sp3 resonance of the methoxy group and 14 sp2 carbon resonances including two typical carbonyls at d 186.9 (C-9) and 182.7 (C-10) ( Table 2) for the 9,10-anthraquinone nucleus [11] [12] [13] [14] [15] [16] . These spectroscopic data revealed that compound 1 was a dihydroxy-methoxy-substituted 9,10-anthraquinone analogue. In the HMBC spectrum of 1, two-and three-bond correlations of OH-1/C-1, C-2, and C-9a and H-2/C-9a, C-3, and C-4, together with the shifts of these proton and carbon resonances located unambiguously the hydrogen bonded hydroxy group at C-1. In addition, HMBC correlations of H-4/C-2, C-3, C-9a, C-10, and C-10a; H-5/C-7, C-8a, C-10, and C-10a; H-8/C-6, C-9, and C-10a; and OMe/C-6 located the remained hydroxy and methoxy groups at C-3 and C-6, respectively. Therefore, compound 1 was determined as 1,3-dihydroxy-6-methoxy-9,10-anthraquinone.
The spectroscopic data of compound 2 (Tables 1 and 2 and Section 3) indicated that it was an isomer of 1 with the methoxy group located at C-1, which was supported by the absence of the hydrogen bonded phenolic hydroxy proton in the 1 H NMR spectrum of 2. This was further confirmed by correlations from the methoxy protons to C-1, from H-2 to C-1, C-3, and C-9a, and from H-4 to C-2, C-3, C-9a, and C-10 in the gHMBC spectrum of 2. Thus, compound 2 was assigned as 3,6-dihydroxy-1-methoxy-9,10-anthraquinone.
Compound 3 had molecular formula C 15 H 10 O 6 as indicated by (À)-HR-ESI-MS at m/z 285.0407 [M-H] À (calcd. for C 15 H 10 O 6 , 285.0405) and NMR data (Tables 1 and 2). The NMR data of 3 indicated that it was a trihydroxy-9,10-anthraquinone analogue with a hydroxymethyl substituent and two pairs of aromatic protons respectively possessing ortho-and para-positions. In the gHMBC spectrum of 3, correlations from H 2 -11 to C-1, C-2, and C-3, from both H-1 and H-8 to C-9, and from H-4 to C-2, C-3, C-10, together with their shifts, revealed that the hydroxymethyl and three hydroxy groups were located at C-2, C-3, C-5, and C-6, respectively. Accordingly, compound 3 was defined as 3,5,6trihydroxy-2-hydroxymethyl-9,10-anthraquinone.
The spectroscopic data of compound 4 (C 17 H 14 O 7 ) (Tables 1  and 2 and Section 3) indicated that it was an analogue of 3 with an O-ethyl group at C-11 and an additional hydrogen-bonded hydroxy group substituted at C-1 or C-4. The gHMBC spectrum of 4 showed correlations of OH-1/C-1, C-2, and C-9a; H-4/C-10, H-8/C-9; and H 2 -11/C-1, C-2, C-3, and OCH 2 CH 3 . This verified the presence and location of the 1-hydroxy and 11-ethoxy groups in 4. Thus, compound 4 was defined as 1,3,5,6-tetrahydroxy-2ethoxymethyl-9,10-anthraquinone. Figure 1 Structures of compounds 1-17, S16, S16a, and S16b.
The spectroscopic data of compound 5 (Tables 1 and 2 and Section 3) showed that it was an analogue of 4 with two methoxy groups respectively substituting the ethoxy and one hydroxy group. In the gHMBC spectrum of 5, protons of the two methoxy groups correlated, respectively, with C-6 and C-11. Accordingly, compound 5 was determined as 1,3,5-trihydroxy-6methoxy-2-methoxymethyl-9,10-anthraquinone.
The spectroscopic data of compound 6 ( Tables 1 and 2 10-anthraquinone 11 , except that NMR resonances of the Oethyl group in 1,3,6-trihydroxy-2-ethoxymethyl-9,10-anthraquinone were replaced by those of an isopropylidene group. In addition, C-1, C-2, C-3, and C-11 in 6 were shielded as compared to 1,3,6-trihydroxy-2-ethoxymethyl-9,10-anthraquinone, suggesting that 6 was the 3-hydroxy-2-hydroxymethyl-acetonide analogue of 1,3,6-trihydroxy-2-ethoxymethyl-9,10-anthraquinone. The suggestion was supported by HMBC correlations from H-11, H 3 -1 0 , and H 3 -3 0 to C-2 0 , and by the molecular formula combined with the shift of C-9 (d C 187.6) in 6 since C-9 resonated at d C o185 in the 9,10-anthraquinones without the hydrogen-bonded OH-1 (compounds 1-5). Therefore, compound 6 was identified as 1,3,6-trihydroxy-2-hydroxymethyl-9,10-anthraquinone-3-hydroxy-2-hydroxymethyl-acetonide. Compound 7, C 19 H 16 O 7 (HR-ESI-MS), showed spectroscopic data (Tables 1 and 2 and Section 3) similar to those of 6. Comparison of the NMR data of 7 and 6 indicated that the resonances of H-5 and OH-6 in 6 were replaced respectively by those of a hydrogen bonded OH and an OMe group in 7.
In addition, H-4 and C-5 and C-10 in 7 were deshielded, as compared to 6, whereas H-7 and H-8 and C-6, C-7, C-8, and C-10a were shielded. This suggested that 7 was an analogue of 6 with the hydroxy and methoxy groups substituted at C-5 and C-6, respectively. The suggestion was confirmed by correlations of H 2 -11/C-1, C-2, C-3, and C-1 0 , OH-1/C-1, C-2, and C-9a, OH-5/C-5, C-6, and C-10a, and OMe-6/C-6 in the gHMBC spectrum. Thus, compound 7 was defined as 1,3,5trihydroxy-2-hydroxymethyl-6-methoxy-9,10-anthraquinone-3-hydroxy-2-hydroxymethyl-acetonide.
Compound 8 was the 6-deoxy analogue of 6 as indicated by its spectroscopic data (Tables 1 and 2 and Section 3) and confirmed by an enhancement of OH-1 upon irradiation of H 2 -11 and enhancements of H-4 and H 2 -11 by irradiation of H 3 -1 0 and H 3 -3 0 in the NOE difference spectrum. Therefore, compound 8 was identified as 1,3-dihydroxy-2-hydroxymethyl-9,10anthraquinone-3-hydroxy-2-hydroxymethyl-acetonide.
Since the anthraquinones containing methoxy, ethoxy, and isopropylidene units, such as compounds 4-8, as well as the reported analogues 9-13 1, 3, 11, 12 , might be solvolytic artifacts produced in the extraction and isolation procedure, chemical transformation of the co-occurring 14 and 15 12 and HPLC-UV-ESI-MS analysis of extracts obtained with a different solvent extraction procedure were carried out. When ethanol or methanol solutions of 14 or 15 were separately stirred at room temperature for 24 h, no product was generated in the solutions as indicated by TLC. However, after the solutions were refluxed for another 12 h, compounds 9 and 10 were obtained in the ethanol solutions, respectively, and compounds 11 and 12 were isolated in the methanol solutions. This demonstrated that the hydroxy group of 2-hydroxymethyl-9,10-anthraquinones was readily etherified with the solvents, indicating that compounds 4, 5, and the reported analogues (9-13) 1,3,11,12 were solvolytic artifacts. This was further confirmed by HPLC-UV-ESI-MS analysis of the extracts. A comparison of those peaks in the chromatograms of the extracts obtained by ultrasonicating the plant material with the solvents for half an hour, to the chromatograms of the extracts prepared by refluxing the plant material with ethanol or methanol for 2 h, indicated the relative intensities for the peaks of 2-hydroxymethylanthraquinones (14-16) were significantly decreased, whereas, the relative intensities of peaks for 2-ethoxymethyl-(4, 9, 10, and 13) or 2-methoxymethyl-9,10-anthraquinones (5, 11, and 12) were significantly increased. Comparison of the chromatograms of the extracts obtained by separately refluxing or ultrasonicating the plant material with acetone indicated that the relative intensities of the peaks for the major components were not changed significantly. In addition, although compounds 6-8 were not distinguished from the extracts by HPLC-UV-ESI-MS analysis, compounds 8 and S16 were obtained in low yields, respectively from the acetone suspensions of 14 and 16 after the suspensions were separately refluxed for 24 h. This suggested that the acetonides of 3-hydroxy-2-hydroxymethyl-9,10-anthraquinones could be formed in the isolation procedures, but the yield was limited due to low solubility of the precursors. The low yields were consistent with the minor amounts of 6-8 obtained in the isolation. Though the mutual conversion of 16 and S16 was reported 17 , in this study, it was found that S16 was instable in solutions at ambient conditions. Further investigation indicated that S16 was decomposed by oxidation into two major products S16a and S16b with different reaction rates and products ratios in CHCl 3 (faster; S16a/S16b, about 3:2) and acetone (slower; S16a/ S16b, about 1:5).
In the in vitro bioassays, at 10 mM, compound 4 protected hepatocytes (WB-F344 cells) damage induced by DL-galactosamine (GalN) with a 28.073.2% inhibition (the positive control bicyclol showed a 27.072.8% inhibition) 18 .
Experimental

Equipment and reagents
IR spectra were recorded as KBr pellets on a Nicolet 5700 FT-IR spectrophotometer. UV spectra were measured on a Cary 300 spectrophotometer. NMR spectra were obtained at 500 or 600 MHz for 1 H, and 125 MHz for 13 C on Inova 500 and 600 MHz spectrometers in DMSO-d 6 , CD 3 OD, Me 2 CO-d 6 or CDCl 3 with solvent peaks being used as references. ESI-MS and HPLC-UV-ESI-MS data were measured with a Q-Trap LC/MS/MS (Turbo Ionspray source) spectrometer. HR-ESI-MS data were respectively measured using a Micromass Autospec-Ultima ETOF and an AccuToFCS JMS-T100CS spectrometers. Column chromatography was performed with silica gel (100-200 or 200-300 mesh, Qingdao Marine Chemical Inc. China) and Sephadex LH-20 (Pharmacia Biotech AB, Uppsala Sweden). HPLC separation was performed on an instrument consisting of a Waters 600 controller, a Waters 600 pump, and a Waters 2487 dual l absorbance detector with an Alltima (250 mm Â 10 mm i.d.) column packed with C 18 (5 mm) . TLC was carried out with glass precoated silica gel GF 254 plates (Yantai Jiangyou Silica Gel Technology Development Co. Ltd., China). Spots were visualised under UV light or by spraying with 10% H 2 SO 4 in 95% EtOH followed by heating. The hepatoprotective effects were determined by a 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay in WB-F344 cells, with some modification. Each cell suspension of 1 Â 10 4 cells in 200 mL of Dulbecco's modified Eagle's medium (DMEM) containing fetal calf serum (10%), penicillin (100 units/mL), and streptomycin (100 mg/mL) was plated in a 96-well microplate and precultured for 24 h at 37 1C under a 5% CO 2 atmosphere. After fresh medium (200 mL) containing bicyclol (the positive control) or test sample was added, the cells were cultured for 1 h. Then, the cultured cells were exposed to 50 mM DL-galactosamine for 24 h. Cytotoxic effects of test samples were measured simultaneously in the absence of DL-galactosamine. The medium was changed into a fresh one containing 0.5 mg/ mL MTT. After 4 h incubation, the medium was removed and 150 mL of DMSO was added to dissolve formazan crystals. The optical density (OD) of the formazan solution was measured on a microplate reader at 490 nm. Inhibition (%) was obtained by the following formula:
Plant materials
inhibition ð%Þ ¼ ½ðOD sample ÀOD control Þ=ðOD normal ÀOD control Þ Â 100%
The Student's t-test for unpaired observations between normal or control and tested samples was carried out to identify statistical differences; P values less than 0.05 were considered as significantly different.
